ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

A CROSS-SECTIONAL RESEARCH TO COMPARE LEVELS OF TROPONIN T AND ANGIOGRAPHIC OUTCOMES IN FLIMSY ANGINA/ NON-ST HEIGHT MYOCARDIAL INFARCTION

AUTHORS:

Dr Javaria Latif, Dr Rafia Sana, Dr Maryam Shakoor

ABSTRACT:

Background: Patients with raised Troponin T levels had progressively complex sore attributes in the standard coronary angiogram. Heart troponin T positive patients had dominatingly multi vessel malady, more noteworthy coronary narrowing and every now and again complex sore morphology. Objective: To decide the relationship between quantitative Troponin T levels and angiographic discoveries in flimsy angina/non-ST height MI. Patient and Methods: This cross-sectional research was carried out at Services Hospital, Lahore (November 2017 to August 2018). Tests for troponin T levels were acquired 6-12 hours after the beginning of chest torment. Patients were assembled into quartiles as per the dimension of troponin T estimated. Coronary angiography was performed in each patient before release. Every single coronary angiogram was assessed without information on clinical or Troponin T status. Results: The mean age was 53.3 + 10.49. 165(76%) were guys. Left primary ailment (LMD) was available in 13.3% (n=28). Three vessels, two vessels and single vessel sickness were available as 41.4%, 27.1% and 26.7% separately. Ordinary coronary angiogram was noted in 4.8%. Over 70% luminal narrowing in any event in 1 vessel was available in 95.2% of the patients, 3.3% has calcification, 67.6% has impediment and 6.2% had unmistakable thrombus too. Conclusion: Our investigation has exhibited that there was a noteworthy relationship between raised quantitative Troponin T levels and number of sailing vessels. Along these lines, Troponin T positive patients ought to be assessed by coronary angiography to know the seriousness of the ailment. Keywords: Unstable Angina, Troponin T, Coronary Angiography, Coronary Artery Disease.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.